Publication:
Selective whole genome amplification of Plasmodium malariae DNA from clinical samples reveals insights into population structure

dc.contributor.authorAmy Ibrahimen_US
dc.contributor.authorErnest Diez Benaventeen_US
dc.contributor.authorDebbie Nolderen_US
dc.contributor.authorStephane Prouxen_US
dc.contributor.authorMatthew Higginsen_US
dc.contributor.authorJulian Muwanguzien_US
dc.contributor.authorPaula Josefina Gomez Gonzalezen_US
dc.contributor.authorHans Peter Fuehreren_US
dc.contributor.authorCally Roperen_US
dc.contributor.authorFrancois Nostenen_US
dc.contributor.authorColin Sutherlanden_US
dc.contributor.authorTaane G. Clarken_US
dc.contributor.authorSusana Campinoen_US
dc.contributor.otherPublic Health Englanden_US
dc.contributor.otherShoklo Malaria Research Uniten_US
dc.contributor.otherLondon School of Hygiene & Tropical Medicineen_US
dc.contributor.otherNuffield Department of Medicineen_US
dc.contributor.otherVeterinarmedizinische Universitat Wienen_US
dc.date.accessioned2020-08-25T12:01:59Z
dc.date.available2020-08-25T12:01:59Z
dc.date.issued2020-12-01en_US
dc.description.abstract© 2020, The Author(s). The genomic diversity of Plasmodium malariae malaria parasites is understudied, partly because infected individuals tend to present with low parasite densities, leading to difficulties in obtaining sufficient parasite DNA for genome analysis. Selective whole genome amplification (SWGA) increases the relative levels of pathogen DNA in a clinical sample, but has not been adapted for P. malariae parasites. Here we design customized SWGA primers which successfully amplify P. malariae DNA extracted directly from unprocessed clinical blood samples obtained from patients with P. malariae-mono-infections from six countries, and further test the efficacy of SWGA on mixed infections with other Plasmodium spp. SWGA enables the successful whole genome sequencing of samples with low parasite density (i.e. one sample with a parasitaemia of 0.0064% resulted in 44% of the genome covered by ≥ 5 reads), leading to an average 14-fold increase in genome coverage when compared to unamplified samples. We identify a total of 868,476 genome-wide SNPs, of which 194,709 are unique across 18 high-quality isolates. After exclusion of the hypervariable subtelomeric regions, a high-quality core subset of 29,899 unique SNPs is defined. Population genetic analysis suggests that P. malariae parasites display clear geographical separation by continent. Further, SWGA successfully amplifies genetic regions of interest such as orthologs of P. falciparum drug resistance-associated loci (Pfdhfr, Pfdhps, Pfcrt, Pfk13 and Pfmdr1), and several non-synonymous SNPs were detected in these genes. In conclusion, we have established a robust SWGA approach that can assist whole genome sequencing of P. malariae, and thereby facilitate the implementation of much-needed large-scale multi-population genomic studies of this neglected malaria parasite. As demonstrated in other Plasmodia, such genetic diversity studies can provide insights into the biology underlying the disease and inform malaria surveillance and control measures.en_US
dc.identifier.citationScientific Reports. Vol.10, No.1 (2020)en_US
dc.identifier.doi10.1038/s41598-020-67568-4en_US
dc.identifier.issn20452322en_US
dc.identifier.other2-s2.0-85087359035en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/58410
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087359035&origin=inwarden_US
dc.subjectMultidisciplinaryen_US
dc.titleSelective whole genome amplification of Plasmodium malariae DNA from clinical samples reveals insights into population structureen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087359035&origin=inwarden_US

Files

Collections